NCT00050726View on ClinicalTrials.gov

Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

PHASE2CompletedINTERVENTIONAL
Enrollment

620

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
HIV Infections
Interventions
DRUG

Interleukin-2

Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

00/00/00

Hvidovre University Hospital@@@Copenhagen, Denmark, Copenhagen

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00050726 - Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 | Biotech Hunter | Biotech Hunter